Interferon-ε loss is elusive 9p21 link to immune-cold tumors, resistant to immune-checkpoint therapy and endogenous CXCL9/10 induction

By sjmartinez • December 27, 2024

Zhao X, Liu B, William WN, Tsanov KM, Ho YJ, Barriga FM, Lim RJ, Trifas M, Du Y, Lowe SW, Dubinett SM, Davoli T, Lippman SM. Interferon-ε loss is elusive 9p21 link to immune-cold tumors, resistant to immune-checkpoint therapy and endogenous CXCL9/10 induction. J Thorac Oncol. 2024 Dec 24:S1556-0864(24)02539-5. doi: 10.1016/j.jtho.2024.12.020. Epub ahead of print. PMID: 39725169.

Tags: chemokines, chromosome 9p, genomic copy number alterations, immunotherapy, interferons, Publications, Pulmonary, Critical Care & Sleep Medicine

Related Posts

Perceived Utility of Cognitive Behavioral Therapy in People With Bowel Disorders of Gut-Brain Interaction

Veraza DI, Waseem MR, Venezia J, Montero AM, Jones S, Kadariya J, Gupta A, Xu H, Shin A. Perceived Utility of Cognitive Behavioral Therapy in[...]

Escherichia coli ST131 Drives Carbapenem Use for E. Coli Bloodstream Infections

Mackow NA, Shao W, Ge L, Komarow L, Jiang J, Boutzoukas A, Chen L, Garcia-Diaz J, Herc ES, Doi Y, Arias CA, Albin O, Saade[...]

Target-Dose Versus Below-Target-Dose ACE Inhibitors and Lower Risk of Kidney Failure in U.S. Veterans with HFrEF

Ahmed AA, Lu F, Zhang S, Raman VK, Patel SS, Morgan CJ, Faselis C, Lam PH, Fonarow GC, Heidenreich PA, Ahmad T, Anker SD, Metra[...]